BioCentury | Apr 2, 2019
Politics & Policy

Scrutiny over insulin pricing intensifies in Washington

...on drug pricing April 9. Invited PBMs include Cigna; CVS Health Corp. and CVS Caremark; Humana Inc....
...said subcommittee Chair Rep. Diana DeGette (D-Colo.). Mary Romeo, Staff Writer Cigna Corp. CVS Health Corp. Eli Lilly and Co. Humana Inc. Novo...
BioCentury | Mar 12, 2019
Politics & Policy

Senators call on PBMs to testify next on drug pricing

...drug pricing. Invited PBMs include Cigna Corp. (NYSE:CI); CVS Health Corp. (NYSE:CVS) and CVS Caremark; Humana Inc....
BioCentury | Nov 16, 2018
Company News

Google Brings Geisinger CEO on Board to Focus on Healthcare

...3. Ryu joined Geisinger in 2016 after serving as president of integrated care delivery at Humana Inc....
BioCentury | Nov 10, 2018
Company News

Google brings Geisinger CEO on board to focus on healthcare

...3. Ryu joined Geisinger in 2016 after serving as president of integrated care delivery at Humana Inc....
...the University of Illinois Hospital & Health Sciences System. Mary Romeo Alphabet Inc. Cleveland Clinic Duke University Geisinger Health System Google Inc. Humana Inc. Stanford...
BioCentury | Jan 31, 2018
Company News

Amazon, Berkshire, JPM healthcare deal rocks incumbents

...not respond to inquiries. The five main insurers -- Aetna Inc. (NYSE:AET), Anthem Inc. (NYSE:ANTM), Humana Inc....
BioCentury | Nov 10, 2017
Company News

Anthem updates Yescarta, Exondys 51 coverage

...approval to Exondys 51 in September 2016 to treat DMD amendable to exon 51 skipping, Humana Inc....
...NYSE:CI) and UnitedHealth Group Inc. (NYSE:UNH) each said they would cover the drug. In July, Humana...
...hours. Anthem Inc. (NYSE:ANTM), Indianapolis, Ind. Business: Cancer, Musculoskeletal Mary Romeo axicabtagene ciloleucel eteplirsen Exondys 51 KTE-C19 Yescarta Anthem Inc. Cigna Corp. Gilead Sciences Inc. Humana Inc. Kite...
BioCentury | Nov 9, 2017
Company News

Anthem updates Yescarta, Exondys 51 coverage

...approval to Exondys 51 in September 2016 to treat DMD amendable to exon 51 skipping, Humana Inc....
...NYSE:CI) and UnitedHealth Group Inc. (NYSE:UNH) each said they would cover the drug. In July, Humana...
...$73.02 on Thursday, while Sarepta lost $0.27 to $52.17. Mary Romeo axicabtagene ciloleucel eteplirsen Exondys 51 Yescarta Anthem Inc. Cigna Corp. Gilead Sciences Inc. Humana Inc. Kite...
BioCentury | Sep 1, 2017
Clinical News

Eliquis lowers stroke, major bleeding in older non-valvular AF patients

...study evaluated 14,214 matched-pair patients receiving Eliquis or warfarin in an insurance claims database from Humana Inc....
...major bleeding Status: Postmarketing study data Milestone: NA Jaime De Leon apixaban BAY 59-7939 BMS-562247-01 dabigatran dabigatran etexilate mesylate Eliquis Pradax Pradaxa Prazaxa rivaroxaban Xarelto Bayer AG Boehringer Ingelheim GmbH Humana Inc. Johnson...
BioCentury | Aug 30, 2017
Clinical News

Eliquis lowers stroke, major bleeding in older NVAF patients

...study evaluated 14,214 matched-pair patients receiving Eliquis or warfarin in an insurance claims database from Humana Inc....
BioCentury | Mar 1, 2017
Financial News

Sarepta's Exondys 51 guidance well below expectations

...meet the same criteria as those in Sarepta's trials (see BioCentury, Sept. 26, 2016) . Humana Inc....
Items per page:
1 - 10 of 53
BioCentury | Apr 2, 2019
Politics & Policy

Scrutiny over insulin pricing intensifies in Washington

...on drug pricing April 9. Invited PBMs include Cigna; CVS Health Corp. and CVS Caremark; Humana Inc....
...said subcommittee Chair Rep. Diana DeGette (D-Colo.). Mary Romeo, Staff Writer Cigna Corp. CVS Health Corp. Eli Lilly and Co. Humana Inc. Novo...
BioCentury | Mar 12, 2019
Politics & Policy

Senators call on PBMs to testify next on drug pricing

...drug pricing. Invited PBMs include Cigna Corp. (NYSE:CI); CVS Health Corp. (NYSE:CVS) and CVS Caremark; Humana Inc....
BioCentury | Nov 16, 2018
Company News

Google Brings Geisinger CEO on Board to Focus on Healthcare

...3. Ryu joined Geisinger in 2016 after serving as president of integrated care delivery at Humana Inc....
BioCentury | Nov 10, 2018
Company News

Google brings Geisinger CEO on board to focus on healthcare

...3. Ryu joined Geisinger in 2016 after serving as president of integrated care delivery at Humana Inc....
...the University of Illinois Hospital & Health Sciences System. Mary Romeo Alphabet Inc. Cleveland Clinic Duke University Geisinger Health System Google Inc. Humana Inc. Stanford...
BioCentury | Jan 31, 2018
Company News

Amazon, Berkshire, JPM healthcare deal rocks incumbents

...not respond to inquiries. The five main insurers -- Aetna Inc. (NYSE:AET), Anthem Inc. (NYSE:ANTM), Humana Inc....
BioCentury | Nov 10, 2017
Company News

Anthem updates Yescarta, Exondys 51 coverage

...approval to Exondys 51 in September 2016 to treat DMD amendable to exon 51 skipping, Humana Inc....
...NYSE:CI) and UnitedHealth Group Inc. (NYSE:UNH) each said they would cover the drug. In July, Humana...
...hours. Anthem Inc. (NYSE:ANTM), Indianapolis, Ind. Business: Cancer, Musculoskeletal Mary Romeo axicabtagene ciloleucel eteplirsen Exondys 51 KTE-C19 Yescarta Anthem Inc. Cigna Corp. Gilead Sciences Inc. Humana Inc. Kite...
BioCentury | Nov 9, 2017
Company News

Anthem updates Yescarta, Exondys 51 coverage

...approval to Exondys 51 in September 2016 to treat DMD amendable to exon 51 skipping, Humana Inc....
...NYSE:CI) and UnitedHealth Group Inc. (NYSE:UNH) each said they would cover the drug. In July, Humana...
...$73.02 on Thursday, while Sarepta lost $0.27 to $52.17. Mary Romeo axicabtagene ciloleucel eteplirsen Exondys 51 Yescarta Anthem Inc. Cigna Corp. Gilead Sciences Inc. Humana Inc. Kite...
BioCentury | Sep 1, 2017
Clinical News

Eliquis lowers stroke, major bleeding in older non-valvular AF patients

...study evaluated 14,214 matched-pair patients receiving Eliquis or warfarin in an insurance claims database from Humana Inc....
...major bleeding Status: Postmarketing study data Milestone: NA Jaime De Leon apixaban BAY 59-7939 BMS-562247-01 dabigatran dabigatran etexilate mesylate Eliquis Pradax Pradaxa Prazaxa rivaroxaban Xarelto Bayer AG Boehringer Ingelheim GmbH Humana Inc. Johnson...
BioCentury | Aug 30, 2017
Clinical News

Eliquis lowers stroke, major bleeding in older NVAF patients

...study evaluated 14,214 matched-pair patients receiving Eliquis or warfarin in an insurance claims database from Humana Inc....
BioCentury | Mar 1, 2017
Financial News

Sarepta's Exondys 51 guidance well below expectations

...meet the same criteria as those in Sarepta's trials (see BioCentury, Sept. 26, 2016) . Humana Inc....
Items per page:
1 - 10 of 53